Back to top Open menu arrow
Download PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Brainstorms October 31, 2000

The New Cholinesterase Inhibitors for Alzheimer's Disease, Part 2: Illustrating Their Mechanisms of Action

J Clin Psychiatry 2000;61(11):813-814

Article Abstract
In last month’s BRAINSTORMS feature, we discussed the distinctive pharmacologic mechanisms of action of 3 new acetylcholinesterase inhibitors, namely donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl).

Also from JCP

Digital Cognitive Intervention in Older People at Risk of Dementia Autoimmune Diseases, Treatments, and Dementia Risk: A Population-Based Case-Control Study from Taiwan Effect of Nature Videos on the Burden of Caregivers of Patients with Dementia

From the Editors

New Series The JCP Podcast Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.

 

About the Authors

This PDF is free for all visitors!

Vol 87 • 2026 • Number 1

Read the Current Issue

ASCP Corner

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

Original Research

How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Brief Report

Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial

Clinical and Practical Psychopharmacology

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
View current Issue

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe